Trial Profile
Retrospective study of SM-88 in subjects with cancer
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 25 Jun 2018
Price :
$35
*
At a glance
- Drugs Racemetyrosine (Primary)
- Indications Breast cancer; Cancer; Ewing's sarcoma; Glioma; Osteosarcoma; Pancreatic cancer; Prostate cancer
- Focus Expanded access; Therapeutic Use
- 25 Jun 2018 New trial record
- 05 Jun 2018 Results (n=83) presented at the 54th Annual Meeting of the American Society of Clinical Oncology